Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-1 of 1
Keywords: Oxybutynin
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Further Areas
P. Caione, F. Arena, M. Biraghi, R.M. Cigna, D. Chendi, M.L. Chiozza, A. De Lisa, E. De Grazia, M. Fano, P. Formica, S. Garofalo, R. Gramenzi, M. von Heland, P. Lanza, T. Lanza, S. Maffei, C. Manieri, E. Merlini, L. Miano, S. Nappo, A. Pagliarulo, F. Paolini Paoletti, A.C. Pau, D. Porru, G. Riccipetitoni, R.M. Scarpa, P. Seimandi, W. Artibani
Journal:
European Urology
European Urology (1997) 31 (4): 459–463.
Published Online: 11 August 2017
... of two of the most popular drugs, desmopressin(DDAVP) and oxybutynin. Methods: 114 enuretic patients were enrolled in the study. After a 2-week observation period, 66 patients with primary monosymptomatic enuresis were treated with DDAVP, 30 μg/day intranasally, for 6 weeks. 48 patients with enuresis...
